K-numberK243324
Device nameMasimo O3 Regional Oximeter
ApplicantMasimo Corporation
Product codeMUD
Device classClass II
Decision dateJul 17, 2025
DecisionSubstantially Equivalent
Regulation870.2700
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Masimo O3 Regional Oximeter is a noninvasive device that continuously measures regional hemoglobin oxygen saturation (rSO2) in tissue beneath applied sensors. It provides absolute and trending measurements for adults, pediatrics, and neonates across cerebral and non-cerebral sites, plus hemoglobin-related parameters (ΔO2Hb, ΔHHb, ΔcHb) for monitoring relative hemoglobin changes.

Technological characteristics

The device uses multi-distance diffusion spectroscopy to analyze light at different wavelengths and path lengths through tissue, detecting oxygenated and deoxygenated hemoglobin states. No hardware or software changes were made from the predicate device K214072; the only difference is expanded indications for delta features to include pediatric and neonatal populations on both cerebral and non-cerebral sites.

Test standards cited

IEC 60601-1 (electrical safety), IEC 60601-1-2 (electromagnetic compatibility), and accuracy specifications measured in ARMS (average root mean square) for rSO2 trending (3%) and absolute measurements (4-5% depending on population and site).

Substantial equivalence argument

The subject device has identical intended use, principle of operation, mechanism of action, and components as the predicate K214072. Since no hardware or software changes were made, all prior bench testing, biocompatibility, electrical safety, and usability testing remain valid. The only substantive change is expanded indications for delta features across pediatric and neonatal populations and non-cerebral sites; this is supported by two clinical studies (25 and 29 subjects respectively) demonstrating equivalent performance and strong correlation for the delta features in these new populations.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →